期刊文献+

SUMO特异性蛋白酶1在动脉粥样硬化发病机制中的作用 被引量:4

Role of SUMO-specific protease 1 in pathogenesis of atherosclerosis
暂未订购
导出
摘要 目的探讨SUMO特异性蛋白酶1(SENP1)在小鼠动脉粥样硬化发病机制中的作用。方法采用主动脉整体和主动脉根部油红O染色以及主动脉根部巨噬细胞标志物MOMA-2的免疫组织化学染色,观察SENP1+/+X Apoe-/-(n=5)与SENP1+/-XApoe-/-(n=4)两组小鼠在饲喂高胆固醇高脂食物后动脉粥样硬化病理改变。采用乙酰化低密度脂蛋白(ac-LDL)诱导巨噬细胞RAW264.7泡沫化,油红O染色检测RAW264.7 si-ns及RAW264.7 si-SENP1的泡沫细胞形成能力。采用Real-Time PCR和Western blotting分别检测RAW264.7 si-ns和RAW264.7 si-SENP1中脂肪酸结合蛋白4(FABP4)mRNA和蛋白的相对表达量。结果饲喂高胆固醇高脂食物后,油红O染色显示,SENP1+/-X Apoe-/-小鼠的斑块相对面积(斑块面积/血管总面积)和主动脉弓斑块面积均大于SENP1+/+X Apoe-/-小鼠,分别为(6.716±1.442)%和(5.952±2.332)%以及(364 249±45 838)和(273 486±158 814)μm2;免疫组织化学染色显示,主动脉根部巨噬细胞面积/斑块面积分别为(41.00±0.05)%和(40.47±0.07)%,差异无统计学意义(P=0.954)。Real-Time PCR和Western blotting检测以及油红O染色结果显示,RAW264.7 si-SENP1的FABP4表达水平及泡沫细胞形成能力均较RAW264.7 si-ns高。结论 SENP1通过下调FABP4的表达,抑制巨噬细胞源性泡沫细胞形成,从而抑制动脉粥样硬化的发生。 Objective To investigate the potential role of SUMO-specific protease I (SENPI) in the pathogenesis of atherosclerosis in mice. Methods The development of atheroselerosis in SENP1^+/^+X Apoe^+/^+mice (n = 5) and SENP1^+/^+X Apoe^+/^+mice (n =4) fed with high cholesterol and high fat diet was observed with whole aorta and aorta root oil red O staining and aorta root immunohistochemical staining of macrophage marker MOMA-2, Acetylated low density lipoprotein (ac-LDL) was used to induce the formation of foam cells and oil red O staining, and the capacities of foam cell formation were compared between RAW264.7 si-ns and RAW264.7 si-SENP1. The relative expression of fatty acid-binding protein 4 (FABP4) mRNA and protein in RAW264.7 si-ns and RAW264.7 si-SENP1 was detected by Real-Time PCR and Western blotting. Results Oil red O staining indicated that after feeding with high cholesterol and high fat diet, the relative atherosclerotic lesion areas (lesion areas/total vessel areas) and aorta arch lesion areas of SENP1^+/^+X Apoe^+/^+mice were significantly larger than those of SENP1^+/^+X Apoe^+/^+ mice [ (6. 716± 1. 442) % vs (5. 952± 2. 332) % and (364 249± 45 838) μm^2 vs (273 486 ± 158 814) ~m2]. Immunohistochemical staining revealed that the macrophage area/ plaque area in aorta root inSENP1^+/^+X Apoe^+/^+mice and SENP1^+/^+X Apoe^+/^+ mice were (41.00 ± 0.05)% and (40.47± 0.07)% respectively, and there was no significant difference between them (P = 0.954). Real-Time PCR, Western blotting and oil red O staining demonstrated that FABP4 level and capacity of foam cell formation of RAW264.7si-SENP1 were significantly higher than those of RAW264.7 si-ns. Conclusion SENP1 may suppress the expression of FABP4 and capacity of foam cell formation of macrophages, thus may inhibit the development of atherosclerosis.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2012年第8期1056-1061,共6页 Journal of Shanghai Jiao tong University:Medical Science
关键词 动脉粥样硬化 泡沫细胞 SUMO特异性蛋白酶1 脂肪酸结合蛋白4 atherosclerosis foam cell SUMO-specific protease 1 fatty acid-binding protein 4
  • 相关文献

二级参考文献15

  • 1Glass CK, Saijo K. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat Rev lmmunol 2010; 10:365- 376.
  • 2Medzhitov R, Homg T. Transcriptional control of the inflammatory response. Nat Rev lmmuno12009; 9:692-703.
  • 3Ghisletti S, Huang W, Ogawa S, et al. Parallel SUMOylation-dependent path- ways mediate gene- and signal-specific transrepression by LXRs and PPAR- amma. Mol Cell 2007; 25:57-70.
  • 4Pascual G, Fong AL, Ogawa S, et al. A SUMOylation-dependent pathway mediates transrepression of inflamma- tory response genes by PPAR-gamma. Nature 2005; 437:759-763.
  • 5Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf D J, Tontonoz E Recip- rocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 2003; 9:213 -219.
  • 6Ricote M, Li AC, Willson TM, Kelly C J, Glass CK. The peroxisome prolif- erator-activated receptor-gamma is a negative regulator of macrophage acti- vation. Nature 1998; 391:79-82.
  • 7Yoon HG, Chan DW, Huang ZQ, et al. Purification and functional charac- terization of the human N-CoR com- plex: the 'roles of HDAC3, TBL1 and TBLR1. EMBOJ2003; 22:1336-1346.
  • 8Venteclef N, Jakobsson T, Ehrlund A, et al. GPS2-dependent corepressor/ SUMO pathways govern anti-inflammatory actions of LRH-1 and LXR-be- ta in the hepatic acute phase response. Genes Dev 2010; 24: 381-395.
  • 9Hargreaves DC, Horng T, Medzhitov R. Control of inducible gene expres- sion by signal-dependent transcriptional elongation. Cell 2009; 138:129-145.
  • 10Treuter E, Venteclef N. Transcriptional control of metabolic and inflammatory pathways by nuclear receptor SUMOy- lation. Biochim Biophys Acta 2010 Dec 21; doi: 10.1016/j.bbadis.2010.12.008.

同被引文献29

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1379
  • 2Burdelski C,Menan D,Tsourlakis MC,et al.The prognostic value of SUMO1/Sentrin specific peptidase 1(SENP1)in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion[J].BMC Cancer,2015(15):538.
  • 3Bawa-Khalfe T,Cheng J,Wang Z,et al.Induction of the SUMOspecific protease 1 transcription by the androgen receptor in prostate cancer cells[J].J Biol Chem,2007,282(52):37341-37349.
  • 4Cheng J,Wang D,Wang Z,et al.SENP1 enhances androgen receptor dependent transcription through desumoylation of histone deacetylase 1[J].Mol Cell Biol,2004,24(13):6021-6028.
  • 5Siegel R,Ma J,Zou Z,et al.Cancer statistics,2014[J].CA Cancer J Clin,2014,64(1):9-29.
  • 6Gill G.SUMO and ubiquitin in the nucleus:different functions,similar mechanisms[J].Genes Dev,2004,18(17):2046-2059.
  • 7Girdwood D,Bumpass D,Vaughan OA,et al.P300 transcriptional repression is mediated by SUMO modification[J].Mol Cell,2003,11(4):1043-1054.
  • 8Wu HJ,Sun L,Zhang Y,et al.Coordinated regulation of AIB1transcriptional activity by sumoylation and phosphorylation[J].J Biol Chem,2006,281(31):21848-21856.
  • 9Wang Q,Xia N,Li T,et al.SUMO-specific protease 1 promotes prostate cancer progression and metastasis[J].Oncogene,2013,32(19):2493-2498.
  • 10Van Nguyen T,Angkasekwinai P,Dou H,et al.SUMO-specific protease 1 is critical for early lymphoid development through regulation of STAT5 activation[J].Mol Cell,2012,45(2):210-221.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部